Table 1.
Demographics, n | 13 |
Median age, years (range) | 62.2 (33.7–74.0) |
Sex, n (%) | |
Male | 9 (69.2) |
Female | 4 (30.8) |
Nationality, n (%) | |
Lebanese | 8 (61.5) |
Iraqi | 2 (15.4) |
Jordanian | 3 (23.1) |
ECOG performance status, n (%) | |
≤ 1 | 13 (100) |
> 1 | 0 (0) |
MMR mutational status, n (%) | |
MSS | 13 (100) |
MSI-H | 0 (0) |
Tumor histology type, n (%) | |
Intestinal | 10 (76.9) |
Mucinous | 1 (7.7) |
Combined Mucinous and Intestinal | 1 (7.7) |
Combined Signet ring cell and Intestinal | 1 (7.7) |
Tumor differentiation, n (%) | |
Well | 2 (15.3) |
Moderate | 10 (77) |
Poorly | 1 (7.7) |
Median distance from anal verge, cm (range) | 10 (3–14) |
Clinical stage, n (%) | |
TxN1 | 1 (7.7) |
T3N0 | 1 (7.7) |
T3N1 | 4 (30.8) |
T3N2 | 7 (53.8%) |
ECOG, Eastern Cooperative Group Oncology Status; MMR, mismatch repair; MSI-H, microsatellite instability-high; MSS, microsatellite-stable